StonvexLoading…
StonvexStonvexStonvexCore line items from HNOI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-01-31 | Annual 2025 2025-10-31 | Q3 2025 2025-07-31 | Q2 2025 2025-04-30 |
|---|---|---|---|---|
Revenue | $0.00 | $65.56K | $43.71K | $43.71K |
Operating Income | $-182.07K | $-6.62M | $-6.43M | $-5.93M |
Net Income | $-182.07K | $-6.62M | $-6.43M | $-5.93M |
EPS (Diluted) | $0.00 | $-0.04 | $-0.04 | $0.03 |
Total Assets | $1.39M | $1.73M | $1.51M | $1.64M |
Total Liabilities | $3.09M | $3.36M | $3.07M | $3.33M |
Cash & Equivalents | $81.49K | $9.53K | $31.98K | $72.61K |
Free Cash Flow OCF − CapEx | $-125.53K | $-1.19M | $-1.06M | $-849.14K |
Shares Outstanding | 101.82M | 100.80M | 95.92M | 80.15M |